Literature DB >> 10940235

Prions of yeast as heritable amyloidoses.

R B Wickner1, K L Taylor, H K Edskes, M L Maddelein, H Moriyama, B T Roberts.   

Abstract

Two infectious proteins (prions) of Saccharomyces cerevisiae have been identified by their unusual genetic properties: (1) reversible curability, (2) de novo induction of the infectious prion form by overproduction of the protein, and (3) similar phenotype of the prion and mutation in the chromosomal gene encoding the protein. [URE3] is an altered infectious form of the Ure2 protein, a regulator of nitrogen catabolism, while [PSI] is a prion of the Sup35 protein, a subunit of the translation termination factor. The altered form of each is inactive in its normal function, but is able to convert the corresponding normal protein into the same altered inactive state. The N-terminal parts of Ure2p and Sup35p (the "prion domains") are responsible for prion formation and propagation and are rich in asparagine and glutamine residues. Ure2p and Sup35p are aggregated in vivo in [URE3]- and [PSI]-containing cells, respectively. The prion domains can form amyloid in vitro, suggesting that amyloid formation is the basis of these two prion diseases. Yeast prions can be cured by growth on millimolar concentrations of guanidine. An excess or deficiency of the chaperone Hsp104 cures the [PSI] prion. Overexpression of fragments of Ure2p or certain fusion proteins leads to curing of [URE3]. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10940235     DOI: 10.1006/jsbi.2000.4250

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  26 in total

1.  Gln3p nuclear localization and interaction with Ure2p in Saccharomyces cerevisiae.

Authors:  A A Kulkarni; A T Abul-Hamd; R Rai; H El Berry; T G Cooper
Journal:  J Biol Chem       Date:  2001-06-14       Impact factor: 5.157

2.  Amyloid aggregates of the HET-s prion protein are infectious.

Authors:  Marie-Lise Maddelein; Suzana Dos Reis; Stéphane Duvezin-Caubet; Bénédicte Coulary-Salin; Sven J Saupe
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

3.  Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation.

Authors:  Bishwajit Kundu; Nilesh R Maiti; Eric M Jones; Krystyna A Surewicz; David L Vanik; Witold K Surewicz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

4.  Localization of HET-S to the cell periphery, not to [Het-s] aggregates, is associated with [Het-s]-HET-S toxicity.

Authors:  Vidhu Mathur; Carolin Seuring; Roland Riek; Sven J Saupe; Susan W Liebman
Journal:  Mol Cell Biol       Date:  2011-10-28       Impact factor: 4.272

5.  High pressure, a tool to switch between soluble and fibrillar prion protein structures.

Authors:  Joan Torrent; Reinhard Lange
Journal:  Commun Integr Biol       Date:  2012-01-01

6.  Generation of prions in vitro and the protein-only hypothesis.

Authors:  Rodrigo Diaz-Espinoza; Claudio Soto
Journal:  Prion       Date:  2010-04-05       Impact factor: 3.931

Review 7.  More than Just a Phase: Prions at the Crossroads of Epigenetic Inheritance and Evolutionary Change.

Authors:  Anupam K Chakravarty; Daniel F Jarosz
Journal:  J Mol Biol       Date:  2018-07-19       Impact factor: 5.469

8.  The mechanisms of [URE3] prion elimination demonstrate that large aggregates of Ure2p are dead-end products.

Authors:  Leslie Ripaud; Laurent Maillet; Christophe Cullin
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

9.  Propagation of Saccharomyces cerevisiae [PSI+] prion is impaired by factors that regulate Hsp70 substrate binding.

Authors:  Gary Jones; Youtao Song; Seyung Chung; Daniel C Masison
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

10.  Independent regulation of Hsp70 and Hsp90 chaperones by Hsp70/Hsp90-organizing protein Sti1 (Hop1).

Authors:  Youtao Song; Daniel C Masison
Journal:  J Biol Chem       Date:  2005-08-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.